Integrated Diagnostics Holdings Balance Sheet Health
Financial Health criteria checks 6/6
Integrated Diagnostics Holdings has a total shareholder equity of EGP3.6B and total debt of EGP94.1M, which brings its debt-to-equity ratio to 2.6%. Its total assets and total liabilities are EGP6.8B and EGP3.2B respectively. Integrated Diagnostics Holdings's EBIT is EGP948.7M making its interest coverage ratio 18.1. It has cash and short-term investments of EGP1.3B.
Key information
2.6%
Debt to equity ratio
ج.م94.08m
Debt
| Interest coverage ratio | 18.1x |
| Cash | ج.م1.29b |
| Equity | ج.م3.55b |
| Total liabilities | ج.م3.22b |
| Total assets | ج.م6.77b |
Recent financial health updates
Is Integrated Diagnostics Holdings (LON:IDHC) A Risky Investment?
Oct 17
Does Integrated Diagnostics Holdings (LON:IDHC) Have A Healthy Balance Sheet?
Sep 06Recent updates
Integrated Diagnostics Holdings (LON:IDHC) Will Be Hoping To Turn Its Returns On Capital Around
Nov 07Is Integrated Diagnostics Holdings (LON:IDHC) A Risky Investment?
Oct 17Returns On Capital Signal Tricky Times Ahead For Integrated Diagnostics Holdings (LON:IDHC)
Jun 22Integrated Diagnostics Holdings' (LON:IDHC) Problems Go Beyond Weak Profit
Nov 25Does Integrated Diagnostics Holdings (LON:IDHC) Have A Healthy Balance Sheet?
Sep 06Financial Position Analysis
Short Term Liabilities: IDHC's short term assets (EGP2.7B) exceed its short term liabilities (EGP1.7B).
Long Term Liabilities: IDHC's short term assets (EGP2.7B) exceed its long term liabilities (EGP1.5B).
Debt to Equity History and Analysis
Debt Level: IDHC has more cash than its total debt.
Reducing Debt: IDHC's debt to equity ratio has reduced from 5.3% to 2.6% over the past 5 years.
Debt Coverage: IDHC's debt is well covered by operating cash flow (891.8%).
Interest Coverage: IDHC's interest payments on its debt are well covered by EBIT (18.1x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 00:41 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Integrated Diagnostics Holdings plc is covered by 11 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Aly Adel | Beltone Financial |
| Alia El Mehelmy | CI Capital Research |
| Marc Hammoud | Deutsche Bank |